Sterling Pharma Solutions

Overview

Sterling Pharma Solutions is a partnership development and manufacturing organisation (PDMO®) with over 50 years of experience delivering small molecule API development and manufacturing solutions. The company serves biotechs and pharmaceutical companies across the entire product lifecycle, from early-stage discovery to full commercial roll-out.

Core Capabilities

API Development & Manufacturing: Comprehensive services spanning route scouting, design, process optimization, and clinical supply to commercial cGMP manufacturing. Capable of supporting projects from grammes to tonnes in-house.

ADC Development & Manufacturing: Dedicated bioconjugation team with years of experience supporting ADC projects from discovery and development through preclinical and clinical cGMP manufacture.

Lifecycle Support: Full-service capabilities across discovery, preclinical, Phase I, Phase II, Phase III, and commercial launch phases, with emphasis on process development, quality by design, design of experiments, and CMC regulatory support.

Differentiators

• Scientific Partnership Model: Transparent, collaborative approach emphasizing true partnership over transactional outsourcing
• Complex Chemistry Expertise: Significant experience with hazardous and complex chemical transformations
• Global Facility Network: Purpose-built facilities across UK, USA, and Europe with state-of-the-art equipment and cGMP accreditation
• Innovation Focus: Technology and Innovation Programme partnering with leading academic and technological institutions to apply emerging technologies
• Specialized Teams: Over 1,350 team members with expertise in chemistry, biology, process design, quality assurance, and engineering